Orient Pharma Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep '24 Sep 9, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Market Capitalization	5,799	4,461	3,908	3,497	2,721	2,266
Market Cap Growth	8.40%	14.13%	11.76%	28.52%	20.11%	-7.39%
Enterprise Value	6,280	5,080	4,148	3,763	3,110	2,513
Last Close Price	26.00	20.00	20.90	18.70	14.55	13.39
PE Ratio	48.69	200.14	-135.90	-34.07	-14.38	-10.40
PS Ratio	5.44	5.01	7.64	7.55	6.60	6.41
PB Ratio	3.27	2.67	3.59	3.13	2.24	2.30
P/FCF Ratio	39.96	-28.39	-229.73	-29.12	-12.24	-14.59
P/OCF Ratio	35.40	-43.31	343.32	-65.28	-18.39	-17.44
EV/Sales Ratio	5.89	5.71	8.10	8.12	7.55	7.11
EV/EBITDA Ratio	22.46	36.55	333.67	-45.72	-27.20	-16.68
EV/EBIT Ratio	43.61	208.88	-99.37	-28.19	-18.65	-12.24
EV/FCF Ratio	43.28	-32.33	-243.78	-31.33	-13.99	-16.18
Debt / Equity Ratio	0.37	0.43	0.47	0.37	0.27	0.37
Debt / EBITDA Ratio	2.37	4.52	20.74	-	-	-
Debt / FCF Ratio	4.56	-4.56	-29.87	-3.46	-1.46	-2.37
Asset Turnover	0.41	0.40	0.28	0.26	0.25	0.23
Inventory Turnover	2.03	1.97	2.03	2.17	2.67	3.20
Quick Ratio	0.71	0.53	0.51	0.55	1.08	0.45
Current Ratio	1.32	1.10	1.21	1.05	1.73	0.91
Return on Equity (ROE)	6.97%	1.61%	-2.61%	-8.80%	-15.56%	-18.60%
Return on Assets (ROA)	3.48%	0.69%	-1.44%	-4.76%	-6.30%	-8.32%
Return on Capital (ROIC)	3.74%	0.76%	-1.67%	-5.43%	-7.20%	-9.60%
Earnings Yield	2.05%	0.50%	-0.74%	-2.94%	-6.30%	-8.87%
FCF Yield	2.50%	-3.52%	-0.44%	-3.43%	-8.17%	-6.86%
Buyback Yield / Dilution	-8.79%	-19.27%	0.00%	-10.40%	-8.57%	-0.15%
Total Shareholder Return	-8.79%	-19.27%	0.00%	-10.40%	-8.57%	-0.15%

Source: S&P Capital IQ. Standard template. Financial Sources.